Sunstone Life Science Ventures
Claus Andersson is a General Partner at Sunstone Life Science Ventures, overseeing investments in prescription drugs based on new chemical entities and active pharmaceutical ingredients with well-described mechanisms of action. Claus also serves on the Board of Directors for multiple biotech companies, including Resalis Therapeutics, DiogenX, Rewind Therapeutics, Cardior Pharmaceuticals, and others. Claus has a background in multivariate statistics and chemical engineering from the University of Copenhagen and the Technical University of Denmark.
Sunstone Life Science Ventures
3 followers
Sunstone Life Science Ventures’ is a European, early-stage investor based in Copenhagen. Sunstone Life Science Ventures invests in drug development opportunities across the European Life Science sector, and prefer to make initial investment in companies raising Series A/B rounds based on solid in-vivo preclinical data and a well understood mechanism of action that fits well into the pathology.